英文别名 |
inokosterone;5-beta-Cholest-7-en-6-one, 2-beta,3-beta,14,20,22,26-hexahydroxy-, (22R,25RS)-;Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2-beta,3-beta,5-beta,22R)- (9CI);2,3,14,20,22,26-hexahydroxycholest-7-en-6-one;(2beta,3beta,5beta,22R,25R)-2,3,14,20,22,26-hexahydroxycholest-7-en-6-one;Lnokosterone;(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,6R)-2,3,7-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one;Cholest-7-en-6-one,2,3,14,20,22,26-hexahydroxy-, (2b,3b,5b,22R)-;(22R)-2β,3β,14,20,22,26-Hexahydroxy-5β-cholest-7-en-6-one;CS-0032159;FS-8110;19682-38-3;SCHEMBL143421;C08819;Q27103165;(22R,25R)-2beta,3beta,14,20,22,26-hexahydroxy-5beta-cholest-7-en-6-one;LMST01010194;DTXSID40164756;CHEBI:27495;PD125550;Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2-beta,3-beta,5-beta,22R)-;25R-Inokosterone;AKOS015896810;15130-85-5;HY-N4131;2,3,14-trihydroxy-10,13-dimethyl-17-(2,3,7-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one;NSC342715;AKOS040761862;88980-54-5;CHEMBL1967672;DTXSID30915350;NSC-342715;PD125551;94720-16-8;(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-((2R,3R,6R)-2,3,7-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta(a)phenanthren-6-one;DA-54329;Inokosterone;Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2-beta,3-beta,5-beta,22R)-(9CI);Calinecdysone A;DTXCID9087247;5-beta-Cholest-7-en-6-one, 2-beta,3-beta,14,20,22,26-hexahydroxy-, (22R,25rs)-;Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2-beta,3-beta,5-beta,22R)- (9ci) |